Novel Thiazolidine‐2,4‐Dione Derivatives as Potential VEGFR‐2 Inhibitors: Synthesis, Biological Testing, and in Silico Studies

Ejemplares similares

• Innovative Nicotinamide‐Dihydrothiadiazole Compounds for Targeting VEGFR‐2: Design, Synthesis, and Mechanistic Exploration in Breast Cancer Treatment
  por: Ahmed M. Metwaly, et al.
  Publicado: (2025)
• Development of New Thiadiazole Derivatives as VEGFR‐2 Inhibitors With Anticancer and Proapoptotic Activities‏
  por: Hazem Elkady, et al.
  Publicado: (2025)
• New 1,3,4‐Thiadiazole‐Based Dual B‐Raf/VEGFR‐2 Inhibitors With Potential Anti‐Breast Activity: Design, Synthesis, In Vitro and In Silico Evaluations
  por: Walid E. Elgammal, et al.
  Publicado: (2025)
• Design and In Silico and In Vitro Evaluations of a Novel Nicotinamide Derivative as a VEGFR-2 Inhibitor
  por: Ibrahim H. Eissa, et al.
  Publicado: (2024)
• Structure‐Guided Design and Mechanistic Elucidation of New Chromene Derivatives as Selective Vascular Endothelial Growth Factor Receptor‐2 Inhibitors With Potent Anticancer Activity
  por: Hazem Elkady, et al.
  Publicado: (2026)